- Record: found
- Abstract: not found
- Article: not found
A phase II study of palonosetron combined with dexamethasone to prevent nausea and vomiting induced by highly emetogenic chemotherapy
M. Maemondo ,
N. Masuda ,
I. Sekine ,
K. Kubota ,
Y. Segawa ,
M. Shibuya ,
F. Imamura ,
N. Katakami ,
T. Hida ,
S. Takeo
November 2009
November 2009
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
This is a randomized, double-blind, dose-ranging study in patients receiving highly
emetogenic chemotherapy (HEC) to evaluate the safety, efficacy, and pharmacokinetics
of palonosetron, in combination with dexamethasone.